A recent cross-sectional study has established new reference values for D-lactate in healthy children while identifying a significant increase in serum and urinary concentrations among pediatric patients who have undergone bowel adaptation following intestinal failure. As the minor enantiomer of lactate, D-lactate is produced primarily by intestinal microbiota or through endogenous processes like the methylglyoxal pathway, and it is converted into pyruvate in the liver to enter the tricarboxylic acid cycle. While the metabolic roles and pathogenic implications of D-lactate remain areas of active scientific investigation, the current study provides essential baseline data, filling a critical gap in existing pediatric literature where data on healthy individuals have been sparse.
The study, which spanned five tertiary centers in the Czech Republic, involved a total of 341 samples—184 serum and 157 urine—collected from 129 Caucasian children. Researchers categorized these participants into five distinct groups: patients receiving home parenteral nutrition, children who had achieved bowel adaptation following intestinal failure, individuals on home enteral nutrition via percutaneous endoscopic gastrostomy, those with other gastrointestinal disorders, and a healthy control group. To ensure scientific rigor and provide a reliable physiological baseline, the control group consisted of 55 children undergoing minor elective procedures, such as hernia repair, who had no history of gastrointestinal surgery, active infection, or specific dietary restrictions.
For the healthy control cohort, the study identified median serum D-lactate levels of 28.5 micromoles per liter, with an interquartile range of 25 to 34.25 micromoles per liter, and median urinary levels of 400 micromoles per liter, ranging from 193 to 722 micromoles per liter. Linear regression analyses indicated no statistically significant associations between age or sex and D-lactate levels, suggesting these reference values are broadly applicable across the pediatric demographic studied. Researchers also calculated a median urinary D-lactate to creatinine ratio of 0.113 micromoles per micromole of creatinine, supporting the utility of urinary markers in reflecting systemic D-lactate burden.
In contrast to the healthy controls, the group of children who had undergone bowel adaptation after experiencing intestinal failure exhibited significantly higher D-lactate concentrations in both serum and urine. Serum levels in this adaptation group were measured at a median of 40 micromoles per liter, while urinary concentrations reached a median of 595 micromoles per liter. These findings are statistically robust, with serum comparisons against healthy controls yielding a p-value of less than 0.001 and urinary comparisons yielding a p-value of 0.011. This observed elevation supports the hypothesis that structural and functional changes in the bowel following intestinal resection may facilitate increased fermentation and subsequent absorption of microbial-derived D-lactate.
Researchers further investigated the potential mechanisms behind these elevated levels, noting that the presence of an intestinal anastomosis was positively associated with higher serum D-lactate concentrations. The study also evaluated biochemical parameters, finding that serum D-lactate was positively associated with the urinary D-lactate to creatinine ratio, while it showed an inverse association with base excess and albumin levels. These associations underscore the complex relationship between systemic D-lactate levels and the nutritional or metabolic status of patients with complex gastrointestinal conditions.
A critical component of the research involved a genetic sub-analysis to determine whether pathogenic variants in the D-lactate dehydrogenase enzyme, the primary enzyme responsible for metabolizing D-lactate in the liver, could account for the observed elevations. Despite sequencing 7,955 clinically significant genes, including the LDHD gene, in two patients who exhibited markedly elevated D-lactate levels without D-lactic acidosis, no pathogenic LDHD variants were identified. While one patient carried heterozygous missense variants in the TTC7A gene—a mutation linked more commonly to multiple intestinal atresia and immunodeficiency—the lack of identified LDHD mutations suggests that the metabolic elevations observed in these patients are likely driven by other factors.
The study highlights important considerations regarding the clinical interpretation of D-lactate measurements. Although elevated, the D-lactate concentrations observed in the bowel-adaptation group remained substantially lower than the levels associated with D-lactic acidosis, which is typically defined by serum elevations exceeding 3,000 micromoles per liter in patients with short bowel syndrome. The findings suggest that while microbial shifts or increased dietary substrate delivery in post-adaptation patients might lead to a measurable rise in D-lactate, the clinical significance of these elevated values in the absence of neurological or metabolic symptoms remains uncertain and requires further longitudinal investigation.
Regarding methodology, the research team utilized enzymatic spectrophotometric assays to ensure consistent quantification across all study sites. However, the authors acknowledged limitations inherent in the study design, including the absence of data on fecal D-lactate concentrations and gut microbiota composition, which would have provided deeper insights into the specific microbial contributors to the systemic D-lactate observed. Furthermore, the limited availability of urinary creatinine data restricted the scope of the D-lactate to creatinine ratio analysis. Despite these constraints, the study provides a foundational reference for clinicians and researchers monitoring pediatric patients with intestinal failure.
Ultimately, the researchers propose that the increased concentrations in children after bowel adaptation may be a result of a combination of hyperphagia, structural colonic changes, and a resultant increase in the delivery of fermentable substrates to the colon. As patients achieve enteral autonomy, the capacity for absorption and the composition of the intestinal microbiome shift, creating a unique metabolic environment. By establishing these initial reference ranges and characterizing the D-lactate profiles of various patient groups, this study provides a vital framework for future work investigating the role of D-lactate as a non-invasive biomarker and its broader impact on pediatric intestinal health and intermediary metabolism.
Beyond healthy controls, the investigation examined differences across the broader clinical cohort of children with a median age of 6.9 years. Patients after bowel adaptation demonstrated higher serum levels than those with other gastrointestinal disorders, whose median was 32 micromoles per liter (p = 0.041), and higher urinary levels than children with gastrostomy feeding (p = 0.045). Between adapted patients and those on parenteral nutrition, concentrations did not differ significantly, and residual bowel lengths were comparable. Healthy controls showed significantly higher weight, height, and body mass index z-scores than parenteral nutrition patients, and higher weight and height z-scores than adapted and gastrostomy cohorts. Extreme serum spikes reached 1,519 micromoles per liter in adaptation and 1,399 micromoles per liter in parenteral nutrition.
The detailed profiles of the two individuals subjected to genetic sequencing offer concrete clinical perspectives on severe metabolic elevations. Both patients had short bowel syndrome on parenteral nutrition with repeated concentrations exceeding 1,000 micromoles per liter. The first patient, a boy with necrotizing enterocolitis, showed persistent elevations reaching 2,000 micromoles per liter in serum and 17,000 micromoles per liter in urine, yet never developed metabolic acidosis. The second patient, a girl with jejunal atresia, experienced recurrent D-lactic acidosis with serum levels reaching 6,000 micromoles per liter, with resting values between episodes frequently exceeding 1,000 micromoles per liter. Sequencing identified two heterozygous missense variants in the TTC7A gene, designated c.1817A>G and c.2014T>C, which are linked to structural intestinal atresia and immunodeficiency rather than enzymatic metabolic dysfunction.
A twelve-patient sub-analysis also demonstrated that serum L-lactate concentrations did not correlate with serum or urinary D-lactate levels (p = 0.981), and all L-lactate values remained strictly normal. This lack of association reflects distinct biological pathways: although both isomers share transport mechanisms, they are regulated independently. The findings also clarify historical debates surrounding clearance kinetics. While early literature suggested mammals possessed limited metabolic capacity and excreted most D-lactate in urine, contemporary evidence confirms that humans metabolize D-lactate efficiently into pyruvate, with only a minor fraction excreted physiologically until clearance pathways saturate at high loads. In seventeen healthy children evaluated for creatinine ratios, urinary D-lactate correlated strongly with the urinary D-lactate to creatinine ratio (R² = 0.449, p < 0.001).
The healthy pediatric baseline established here refines earlier comparative data. A previous study reported a higher mean serum concentration of 53.67 micromoles per liter among surgical controls, but that cohort included only twenty-three children without clearly defined surgical procedures. In contrast, the current healthy group of fifty-five children provides a carefully defined reference median of 28.5 micromoles per liter, aligning closely with reported adult values of approximately 23 micromoles per liter in serum and 18.2 micromoles per millimole of creatinine in urine. Across pediatric literature, reported serum levels vary widely across medical conditions, ranging from about 14 micromoles per liter in diabetic ketoacidosis and 250 micromoles per liter in intestinal failure to over 1,000 micromoles per liter in cystic fibrosis and nearly 4,000 micromoles per liter in perforated appendicitis.
The findings also integrate with broader evidence on intestinal microbiota shifts, mucosal barrier function, and systemic intermediary metabolism. In short bowel syndrome, malabsorbed carbohydrates enter the colon to undergo bacterial fermentation, reducing luminal pH and encouraging the proliferation of acid-tolerant, D-lactate-producing microorganisms such as Lactobacillaceae. Concurrently, compensatory expansion of the colonic mucosal surface and hyperphagia enhance intestinal absorption of these bacterial metabolites. Once absorbed, D-lactate travels via portal circulation to hepatocytes, where enzymatic conversion to pyruvate incorporates it into the tricarboxylic acid cycle, lipid synthesis, and glucose production, functioning as a metabolic shunt within the Cori cycle. This microbial-hepatic axis mirrors experimental findings in metabolic liver disease, where reducing intestinal D-lactate availability significantly decreases hepatic inflammation and fibrosis.
Subject of Research: Pediatric D-lactate concentrations and clinical associations in intestinal failure.
Article Title: Serum and urinary D-lactate in pediatric intestinal failure: clinical associations and reference values
Article References: Halašová, R., Ibrahim, R., Balogová, S., Štichhauer, R., Tichá, A., Hyšpler, R., Skutilová, V., Fencl, F., Bajerová, K., Karásková, E., Véghová-Velgáňová, M., Szitányi, P., Schwarz, J., Koudová, M., Doležal, R., Mečiarová, V., & Melek, J. (2026). Serum and urinary D-lactate in pediatric intestinal failure: clinical associations and reference values. Pediatric Research. https://doi.org/10.1038/s41390-026-05400-x
Image Credits: AI Generated
DOI: 10.1038/s41390-026-05400-x
Keywords: D-lactate, pediatric, intestinal failure, metabolism, bowel adaptation, short bowel syndrome, biomarkers, intestinal microbiota, reference values, gastroenterology, clinical research, metabolic pathways, serum analysis, urinary excretion, LDHD enzyme, TTC7A gene, nutritional status
News Source: Harold Sullivan. (November 16, 2026). Pediatric Intestinal Adaptation Linked to Elevated D-Lactate Levels. Scienmag.



